Construction of m7G subtype classification on heterogeneity of sepsis

Jinru Gong1, Jiasheng Yang1, Yaowei He1

  • 1Department of Pulmonary and Critical Care Medicine, Guangdong Second Provincial General Hospital, Guangzhou, China.

Frontiers in Genetics
|December 12, 2022
PubMed

Insights

This study classifies sepsis based on N7-Methylguanosine (m7G) RNA modification genes, identifying two subtypes with distinct prognoses and immune profiles. This molecular classification aids in understanding sepsis heterogeneity and guiding personalized treatment strategies.

Area of Science:

  • Molecular Biology
  • Immunology
  • Genetics

Background:

  • Sepsis is a life-threatening condition characterized by significant heterogeneity.
  • N7-Methylguanosine (m7G) RNA modification is implicated in various diseases, but its role in sepsis remains under-investigated.
  • Understanding sepsis heterogeneity is crucial for developing effective, personalized treatments.

Purpose of the Study:

  • To establish a molecular classification of sepsis based on m7G-related genes.
  • To reveal the heterogeneity within sepsis subtypes.
  • To explore the underlying molecular and immunological mechanisms driving sepsis subtypes.

Main Methods:

  • Identification of eight m7G-related prognostic genes.
  • Consensus Clustering to define molecular subtypes (C1 and C2).
  • ssGSEA for pathway enrichment analysis, CIBERSORT for immune microenvironment assessment, WGCNA for key gene identification, and RT-PCR for validation.

Main Results:

  • Two distinct molecular subtypes of sepsis (C1 and C2) were identified, with C2 exhibiting a worse prognosis.
  • The C2 subtype showed heightened amino acid metabolism, increased M0 macrophages and activated NK cells, and decreased resting NK cells.
  • C2 subtype displayed higher expression of immune regulatory and inflammation-related genes. NUDT4 and PARN were identified as key genes.
  • Increased expression of NUDT4 was confirmed in sepsis patients via RT-PCR.

Conclusions:

  • Clustering sepsis patients based on m7G-related genes effectively distinguishes patient heterogeneity.
  • The identified subtypes offer insights into distinct molecular and immune landscapes within sepsis.
  • This classification framework supports the development of personalized treatment strategies for sepsis.